Børge Sivertsen Selected Research

Therapeutics

10/2022	Digital cognitive behaviour therapy for insomnia (dCBT-I): Chronotype moderation on intervention outcomes.
1/2022	Using network intervention analysis to explore associations between participant expectations of and difficulties with cognitive behavioural therapy for insomnia and clinical outcome: A proof of principle study.
12/2021	Mode of delivery of Cognitive Behavioral Therapy for Insomnia: a randomized controlled non-inferiority trial of digital and face-to-face therapy.
7/2021	The Effect of Reducing Insomnia Severity on Work- and Activity-Related Impairment.
1/2021	Digital cognitive-behavioural therapy for insomnia compared with digital patient education about insomnia in individuals referred to secondary mental health services in Norway: protocol for a multicentre randomised controlled trial.
1/2020	Effects of digital cognitive behavioural therapy for insomnia on insomnia severity: a large-scale randomised controlled trial.
9/2009	[Insomnia].
5/2008	Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with Zopiclone.
4/2007	Management of insomnia in older adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Børge Sivertsen Research Topics

Disease

23	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2022 - 10/2004
2	Fatigue 10/2022 - 10/2019
2	Neoplasms (Cancer) 01/2016 - 12/2015
2	Sleep Wake Disorders 08/2009 - 10/2004
1	Overweight 02/2021
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Mental Disorders (Mental Disorder) 01/2019
1	Ulcer 10/2017
1	Pain (Aches) 08/2015
1	Sleepiness 02/2015
1	Sleep Apnea Syndromes (Sleep Apnea) 08/2009
1	Nocturnal Myoclonus Syndrome 08/2009
1	Apnea 08/2009

Drug/Important Bio-Agent (IBA)

5	Hypnotics and Sedatives (Sedatives)IBA 01/2016 - 10/2004
3	Polymethyl Methacrylate (Sol)IBA 01/2022 - 02/2015
3	Pharmaceutical PreparationsIBA 01/2019 - 08/2009
3	zopiclone (Zop)IBA 08/2009 - 06/2006
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 10/2021 - 10/2019
1	A-factor (Streptomyces)IBA 02/2021
1	NucleotidesIBA 11/2019
1	Biological ProductsIBA 01/2019
1	C-Reactive ProteinIBA 10/2017
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	HDL CholesterolIBA 10/2017
1	Triglycerides (Triacylglycerol)IBA 10/2017
1	ORALIT (ORS)IBA 12/2013

Therapy/Procedure

9	Therapeutics 10/2022 - 04/2007
1	Patient Care 01/2019
1	Glycemic Control 10/2017
1	Drug Prescriptions 12/2015
1	Drug Therapy (Chemotherapy) 04/2007